We show that WNT4 acts via a novel intracellular mechanism, localizing to the mitochondria instead of canonical secretory/paracrine signaling, ultimately leading to metabolic remodeling with a decrease in glucose metabolism but increase in lipid and/or amino acid metabolism in both ILC and gynecologic cancers. This evidence concerns the gene WNT4 and female reproductive organ cancer.